[Dental changes in patients treated with calcium antagonists].

Vutreshni bolesti Pub Date : 1999-01-01
S Ivanova, A Kiselova-Ianeva, L Dimitrov, N Stanchev
{"title":"[Dental changes in patients treated with calcium antagonists].","authors":"S Ivanova,&nbsp;A Kiselova-Ianeva,&nbsp;L Dimitrov,&nbsp;N Stanchev","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>For a period of 7 years the dental status of 160 patients has been investigated and followed. These patients have been treated with calcium channel blockers and selected in age between 22 and 50 years. Their diagnoses are: m. hypertonicus I-II stage--106, WPW-syndrome--10, stenocardia--18, atrial extrasystolia--26. Duration of treatment--from 1 to 7 years (corinfar, nifedipin, adalat--tabl. 40 mg, taken peroral or chewed, respectively suck; isoptin, verapamil--tabl. 40 mg, diltiazem--tabl. 30 mg, taken peroral. A control group of 60 clinically well people at age from 20 to 48 years was investigated. Under continuous treatment with calcium antagonist (> 1 year) the examined patients are found to have considerable decalcination of the dental enamel and caries more frequent (87.5%) compared to the group of clinically healthy people (65%), also increased number of caries in the same patient in comparison to his dental status before starting the therapy in 108 of 160 (67.5%). The differences in the results are statistically significant (p < 0.001). The number of the discovered caries in patients treated with calcium channel blockers and in the studied groups is also large (4 to 2 on average, i.e. two times more). The results allow to recommend a continuous stomatological control for patients treated with calcium antagonists.</p>","PeriodicalId":23592,"journal":{"name":"Vutreshni bolesti","volume":"31 4","pages":"41-4"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vutreshni bolesti","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

For a period of 7 years the dental status of 160 patients has been investigated and followed. These patients have been treated with calcium channel blockers and selected in age between 22 and 50 years. Their diagnoses are: m. hypertonicus I-II stage--106, WPW-syndrome--10, stenocardia--18, atrial extrasystolia--26. Duration of treatment--from 1 to 7 years (corinfar, nifedipin, adalat--tabl. 40 mg, taken peroral or chewed, respectively suck; isoptin, verapamil--tabl. 40 mg, diltiazem--tabl. 30 mg, taken peroral. A control group of 60 clinically well people at age from 20 to 48 years was investigated. Under continuous treatment with calcium antagonist (> 1 year) the examined patients are found to have considerable decalcination of the dental enamel and caries more frequent (87.5%) compared to the group of clinically healthy people (65%), also increased number of caries in the same patient in comparison to his dental status before starting the therapy in 108 of 160 (67.5%). The differences in the results are statistically significant (p < 0.001). The number of the discovered caries in patients treated with calcium channel blockers and in the studied groups is also large (4 to 2 on average, i.e. two times more). The results allow to recommend a continuous stomatological control for patients treated with calcium antagonists.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[钙拮抗剂治疗患者的牙齿变化]。
对160例患者的牙齿状况进行了为期7年的调查和随访。这些患者接受钙通道阻滞剂治疗,年龄在22岁至50岁之间。他们的诊断是:肥厚分枝杆菌I-II期106例,wpw综合征10例,心绞痛18例,房性室间隔26例。治疗持续时间:1 - 7年(科芬、硝苯地平、阿他拉特)。40毫克,口服或咀嚼,分别吮吸;isoptin,维拉帕米——tabl。40毫克,地尔硫卓。30毫克,口服。选取20 ~ 48岁临床健康人群60例作为对照组。在持续使用钙拮抗剂治疗(> 1年)的情况下,与临床健康人群组(65%)相比,检查的患者发现牙釉质严重脱钙,龋齿发生率更高(87.5%),160名患者中有108名(67.5%)的龋齿数量也比开始治疗前增加。结果差异有统计学意义(p < 0.001)。在接受钙通道阻滞剂治疗的患者和研究组中发现的龋齿数量也很大(平均4至2例,即多出两倍)。该结果允许推荐对接受钙拮抗剂治疗的患者进行持续的口腔控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Acquired immunodeficiency syndrome (AIDS)]. [Secondary systemic amyloidosis A combined with primary glomerulonephritis and systemic diseases]. [The systemic and local immune responses in patients with alcoholic liver cirrhosis depending on hepatitis C viral infection (HCV)]. [Arterial hypertension and obesity--a dangerous combination]. [Cellular immune deficiency in patients with chronic glomerulonephritis].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1